ilomastat has been researched along with Neoplasm Metastasis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, J; Liu, MM; Peng, P; Song, J; Sun, X; Yu, JM; Zhou, L | 1 |
1 other study(ies) available for ilomastat and Neoplasm Metastasis
| Article | Year |
|---|---|
Selective non-zinc binding MMP-2 inhibitors: Novel benzamide Ilomastat analogs with anti-tumor metastasis.
Topics: Anilides; Animals; Antineoplastic Agents; Binding Sites; Cell Line, Tumor; Drug Screening Assays, Antitumor; Humans; Hydrogen Bonding; Hydroxamic Acids; Indoles; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Molecular Docking Simulation; Neoplasm Invasiveness; Neoplasm Metastasis; Rats; Rats, Sprague-Dawley | 2016 |